Non-profit website: free to use. No fees from patients, hospitals or doctors. Not an agency. · Free · Not an agencyAbout this site
Medical oncology · Xinhua Hospital · Shanghai

Dr. Zhu Chuanying朱传营

Associate Chief Physician

Summary compiled from public information, updated 18 Nov 2026. It has not been checked against the hospital website yet. Confirm details with the hospital before you travel.

ZC

Professional overview

Zhu Chuanying is an Associate Chief Physician in the Oncology Department at Xinhua Hospital, specializing in radiotherapy and comprehensive treatment of pediatric and head-and-neck malignancies.

SpecialtyMedical oncology
Clinical titleAssociate Chief Physician
Academic roles—
DepartmentOncology Department
HospitalXinhua Hospital
CityShanghai

Areas of focus

Pediatric medulloblastoma
Pediatric rhabdomyosarcoma
Neuroblastoma
Germinoma
Nasal NK/T-cell lymphoma
Stereotactic radiotherapy for oligometastatic tumors
Radiotherapy for pediatric tumors

Experience & recognition

  • Co-authored 3 Chinese and English medical monographs
  • Published over 10 SCI-indexed articles

Professional roles

  • Member, Radiotherapy Working Group, Pediatric Oncology Society, China Anti-Cancer Association (CACA)
  • Member, Medical Oncology Working Group, Head and Neck Tumor Society, Shanghai Anti-Cancer Association
  • Youth Committee Member, Radiation Oncology Society, Shanghai Anti-Cancer Association
  • Member, Radiation Oncology Society, Shanghai Medical Doctor Association
  • Youth Committee Member, Oncology Society, Shanghai Association of Integrative Medicine

Frequently asked questions

What does Dr. Zhu Chuanying specialize in?

Specializes in diagnosis and treatment of pediatric medulloblastoma, pediatric rhabdomyosarcoma, neuroblastoma, germinoma, and nasal NK/T-cell lymphoma; also practices stereotactic radiotherapy for oligometastatic tumors and radiotherapy for pediatric tumors.

Which hospital and department is Dr. Zhu Chuanying in?

Oncology Department at Xinhua Hospital

Sources

Dr. Zhu Chuanying has not reviewed this page.